<SEC-DOCUMENT>0001179110-20-006528-index.html : 20200522
<SEC-HEADER>0001179110-20-006528.hdr.sgml : 20200522
<ACCEPTANCE-DATETIME>20200522180937
ACCESSION NUMBER:		0001179110-20-006528
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20200520
FILED AS OF DATE:		20200522
DATE AS OF CHANGE:		20200522

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			PITZER KENNETH R
		CENTRAL INDEX KEY:			0001668775

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36033
		FILM NUMBER:		20907400

	MAIL ADDRESS:	
		STREET 1:		901 GATEWAY BLVD
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Theravance Biopharma, Inc.
		CENTRAL INDEX KEY:			0001583107
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		UGLAND HOUSE, SOUTH CHURCH STREET
		CITY:			GEORGE TOWN, GRAND CAYMAN
		STATE:			E9
		ZIP:			KY1-1104
		BUSINESS PHONE:		650-808-6000

	MAIL ADDRESS:	
		STREET 1:		UGLAND HOUSE, SOUTH CHURCH STREET
		CITY:			GEORGE TOWN, GRAND CAYMAN
		STATE:			E9
		ZIP:			KY1-1104
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>edgar.xml
<DESCRIPTION>FORM 4 -
<TEXT>
Document 1 - file: edgar.html

Document 1 - RAW XML: edgar.xml

</DOCUMENT>
</SEC-DOCUMENT>